# Phase 1 Clinical Trial of DW340 and DW330SR + DW1030 Co-administration in Healthy Male Volunteers

> **NCT02380976** · PHASE1 · COMPLETED · sponsor: **Daewon Pharmaceutical Co., Ltd.** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** combination drug: DW330SR, DW1030
- **DRUG:** DW340

## Key facts

- **NCT ID:** NCT02380976
- **Lead sponsor:** Daewon Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2015-10
- **Final completion:** —
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2016-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02380976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02380976, "Phase 1 Clinical Trial of DW340 and DW330SR + DW1030 Co-administration in Healthy Male Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02380976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*